SV2A and schizophrenia: Therefore, we conducted a multimodal [11C]UCB-J PET and 1H-MRS imaging study to test the relationship between the proxy synaptic density marker SV2A and glutamate levels in vivo, hypothesising a negative relationship between the two in schizophrenia.